The US FDA has issued draft guidance supporting the use of Bayesian statistical models in drug and biologic trials, enabling sponsors to integrate prior and real-world data into study designs. This ...
Welcome to Better Box Score Metrics, our analytics column focused primarily on semi-pro statistics and discovering new ways ...
The ability to make adaptive decisions in uncertain environments is a fundamental characteristic of biological intelligence. Historically, computational ...
9don MSN
Mental math's shortcut—pupil dilation suggests people start solving before all numbers are in
People often solve simple arithmetic problems, such as basic addition, subtraction, multiplication or division, in their ...
Deciding how fast to drive, brewing better beer, and winning bar bets — Mark Prell, a respected statistician, offers a modern ...
Researchers have proposed an efficient feature search approach for estimating the state of health of lithium-ion batteries, ...
Why conservatives have a duty to distrust official narratives amid historical and recent government deceptions.
To address the limitations of binary pCR classification, Pusztai and colleagues developed the residual cancer burden (RCB) ...
What research suggests does attract attention is surprise. Specifically, Bayesian surprise, which measures how much information changes your beliefs—the gap between what you believed before and after ...
1. FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results. News release. FDA. April 13, 2026.
Life emerged from the fabled primordial soup, some antediluvian sea. These systems seem alive, and humans increasingly wonder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results